Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa

BACKGROUND: Multi-drug resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) in pregnant women is a cause for concern globally; few data have described the safety of second-line anti-TB medications during pregnancy. We aim to describe TB treatment and pregnancy outcomes among pregnant women re...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokhele, Idah, Jinga, Nelly, Berhanu, Rebecca, Dlamini, Thandi, Long, Lawrence, Evans, Denise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240388/
https://www.ncbi.nlm.nih.gov/pubmed/34182944
http://dx.doi.org/10.1186/s12884-021-03956-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240388/
https://www.ncbi.nlm.nih.gov/pubmed/34182944
http://dx.doi.org/10.1186/s12884-021-03956-6

Ejemplares similares